Catamaran Corp news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

CCT 63.45 -0.57 (-0.89%)
price chart
Shares of Catamaran Corp (USA) Sinks by -4.15% for the Week
Catamaran Corp (USA) (NASDAQ:CTRX) has lost 4.15% during the past week and dropped 4.41% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 1.42%.
Catamaran Corp.: A Different Way to Diversify Your Portfolio
Catamaran Corp. (TSX: CCT) (NASDAQ: CTRX) connects pharmacists, doctors, and caregivers with the prescription data required to improve health results.
Related articles »  
Catamaran Corp.: A Gem in the Healthcare Sector
As you know, your portfolio should typically have exposure to various sectors that do well in different market environments. The healthcare sector, in particular, is considered a defensive one that does well in times of economic uncertainty and weakness.
3 Things That Can Keep the Wind in Catamaran Corp.'s Sails
It's been a relatively rough year for Catamaran Corporation (NASDAQ: CTRX ) so far. Just a couple of weeks ago, the pharmacy benefits manager's stock was down more than 10% and even farther away from the highs seen in 2013.
Related articles »  
Why Catamaran Corp Is a Good Long-Term Growth Stock
When one thinks of technology companies, the usual suspects like BlackBerry Ltd and CGI Group Inc. come to mind. However, there's one lesser-known company that has a good long-term growth story: Catamaran Corp (TSX: CCT)(NASDAQ: CTRX).
Related articles »  
Catamaran Corp Coverage Initiated at Stephens
Analysts at JPMorgan Chase & Co. raised their price target on shares of Catamaran Corp from $54.00 to $56.00 and gave the company an ´┐Żoverweight´┐Ż rating in a research note on Thursday, January 8th.
Catamaran Corp Now Covered by Analysts at Stephens  sleekmoney
Catamaran Corp Earns Overweight Rating from Analysts at Stephens (CTRX)  Mideast Time
Update: Catamaran's Acquisition Of Salveo Specialty Pharmacy (CTRX)
... private American company that was a leader in the specialty pharmacy space, managing $400 million in annual drug spend.
Short Interest of Catamaran Corp (USA) Drops by -3.4%  Bar and Graph Report
Catamaran Corp Downgraded to Underweight at Morgan Stanley
Catamaran Corp logo Morgan Stanley downgraded shares of Catamaran Corp (NASDAQ:CTRX) from an equal weight rating to an underweight rating in a research note released on Tuesday morning, TheFlyOnTheWall.
Catamaran Corp Receives Consensus Recommendation of "Hold" from ...  The Legacy
Catamaran Corp Price Target Raised to $56.00 at JPMorgan Chase & Co.  WKRB News
Catamaran Corp Q3 Earnings Up, Results Beat Estimates; Raises Annual Outlook
Catamaran Corp. now expects annual net earnings of $1.45-$1.50 per share, and adjusted earnings of $2.20-$2.25 per share, on revenues of $21.1 million -$21.5 million.
Related articles »  
Bullish and Outperform S&P 500: Rock-Tenn Company , Catamaran Corp (USA)
Shares of Rock-Tenn Company (NYSE:RKT) rose by 1.31% in the past week and 1.17% for the past 4 weeks. For the past week, the counter has outperformed the S&P 500 by 2.59% and the outperformance increases to 3.73% for the past 4 weeks.